Scleroderma
FY21 Translational Research Partnership Award
The list of Fiscal Year 2021 Scleroderma Research Program Translational Research Partnership Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
Columbia University Medical Center | Elana Bernstein |
University of Pittsburgh | Harinder Singh |
University of Pittsburgh | Robert Lafyatis |
University of Texas Health Science Center at Houston | Shervin Assassi |
University of Texas Health Science Center at Houston | Wenjin Zheng |
Last updated Thursday, May 26, 2022